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Abstract
We previously found that guar gum (GG) and chickpea ﬂour (CPF) added to ﬂatbread wheat ﬂour lowered postprandial blood glucose (PPG)
and insulin responses dose dependently. However, rates of glucose inﬂux cannot be determined from PPG, which integrates rates of inﬂux,
tissue disposal and hepatic glucose production. The objective was to quantify rates of glucose inﬂux and related ﬂuxes as contributors to
changes in PPG with GG and CPF additions to wheat-based ﬂatbreads. In a randomised cross-over design, twelve healthy males consumed
each of three different 13C-enriched meals: control ﬂatbreads (C), or C incorporating 15% CPF with either 2% (GG2) or 4% (GG4) GG. A dual
isotope technique was used to determine the time to reach 50% absorption of exogenous glucose (T50%abs, primary objective), rate of
appearance of exogenous glucose (RaE), rate of appearance of total glucose (RaT), endogenous glucose production (EGP) and rate of
disappearance of total glucose (RdT). Additional exploratory outcomes included PPG, insulin, glucose-dependent insulinotropic peptide and
glucagon-like peptide 1, which were additionally measured over 4 h. Compared with C, GG2 and GG4 had no signiﬁcant effect on T50%abs.
However, GG4 signiﬁcantly reduced 4-h AUC values for RaE, RaT, RdT and EGP, by 11, 14, 14 and 64%, respectively, whereas GG2 showed
minor effects. Effect sizes over 2 and 4 h were similar except for signiﬁcantly greater reduction in EGP for GG4 at 2 h. In conclusion, a soluble
ﬁbre mix added to ﬂatbreads only slightly reduced rates of glucose inﬂux, but more substantially affected rates of postprandial disposal and
hepatic glucose production.
Key words: Dual stable isotope technique: Glucose ﬂuxes: Flatbreads: Viscous ﬁbres: Legume ﬂours
The worldwide prevalence of metabolic diseases such as type 2
diabetes mellitus (T2DM) is rapidly increasing, especially in
China and Southeast Asia(1). Consequently, there is considerable
public health and consumer interest in taking steps to reduce the
risk of these diseases. Repeated exposures to high postprandial
glucose (PPG) and insulin (PPI) responses are implicated in
pre-diabetes and T2DM(2). There is evidence that reducing PPG
reduces progression from pre-diabetes to T2DM and risk of CVD,
as is shown in studies with the α-glucosidase inhibitor Acarbose
or low glycaemic index/glycaemic load diets(3–6).
Carbohydrate-rich staple foods are interesting candidates for
reducing PPG and PPI exposures, because of their widespread
and frequent consumption(7). The two most common
carbohydrate-rich staple foods in South Asia are rice and wheat-
based ﬂatbreads(8), the latter generally prepared at home from
commercially manufactured whole-wheat ﬂour mixes (‘atta’).
Therefore, cost-effective feasible approaches to further reduce
the PPG and PPI response to these staple foods are of interest.
Soluble ﬁbres, especially soluble viscous ﬁbres, can lower
PPG(9). An increased viscosity delays gastric emptying(10) and
inhibits the propulsive and mixing effects of intestinal contrac-
tions(11,12), resulting in a lower PPG(13). In addition, legume
ﬂours, such as chickpea ﬂour (CPF), are known to give a lower
PPG response than wheat ﬂours(14). We observed that viscous
guar gum (GG) added to ﬂatbread ﬂour in combination with
CPF dose dependently lowered PPG and PPI responses(15,16).
It is assumed that viscous gums mainly affect PPG by reducing
rates of glucose absorption(17–20), but testing this hypothesis
Abbreviations: BF, barley ﬂour; C, control; CPF, chickpea ﬂour; dAUC, decremental area under the curve; EGP, endogenous glucose production; GCR, glucose
clearance rate; GG, guar gum; GG2, 2% GG; GG4, 4% GG; GIP, glucose-dependent insulinotropic peptide; GLP-1, glucagon-like peptide 1; PPG, postprandial
plasma glucose; PPI, postprandial plasma insulin; RaE, rate of appearance of exogenous glucose; RaT, rate of appearance of total glucose; RdT, rate of
disappearance of total glucose; T50%abs, time to reach 50% absorption of exogenous glucose.
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would require a determination of glucose ﬂuxes. The PPG
response proﬁle is the net result of the rate of appearance of
glucose from food in the peripheral circulation (rate of appear-
ance of exogenous glucose (RaE); tissue disposal (rate of dis-
appearance of total glucose (RdT); disposal of all glucose to the
tissues); and hepatic glucose production (endogenous glucose
production (EGP); rate of glucose production by the liver)(21).
RaE is a surrogate for glucose absorption in the gut, though
slightly different because it does not take account of liver glucose
uptake on ﬁrst pass metabolism and metabolism of glucose in
enterocytes. The dual stable isotope technique is often applied to
distinguish RaE from other glucose ﬂux parameters(22). For
example, this technique has previously demonstrated that dif-
ferences in the glycaemic responses to some starch-rich foods
reﬂect changes in post-absorptive events more than (as might be
assumed) differences in digestibility and absorption(23).
The present research was therefore carried out in the context
of the general question of how (soluble) ﬁbres in foods inﬂu-
ence glucose ﬂuxes. More speciﬁcally, we wished to establish
this for a commercially feasible combination of soluble viscous
ﬁbre and legume ﬂour in a popular southeast Asian staple food.
The primary objective of this study was to determine the effect
of incorporation of GG and CPF in ﬂatbreads on the rate of
exogenous glucose uptake, expressed as the time to reach 50%
absorption of exogenous glucose (T50%abs). Other objectives,
which contribute to getting an overall picture of glucose
metabolism, were to: (1) estimate the main kinetic parameters,
viz. RaE, rate of appearance of total glucose (RaT), RdT and
EGP, and (2) assess the possible involvement of incretins
(glucagon-like peptide 1 (GLP-1) and glucose-dependent
insulinotropic peptide (GIP)) as contributors directly to the
observed PPI and indirectly to the PPG responses (because of
their potential effects on PPI and gastric emptying). In addition,
the glucose clearance rate (GCR), the rate of plasma volume
being cleared of glucose, was estimated.
Methods
Subjects
A total of ﬁfteen healthy men were recruited locally for screening
from an existing database of potential participants of Quality
Performance Service Netherlands B.V. (Groningen, The
Netherlands), a clinical research organisation (CRO), where the
study was executed. A total of twelve subjects were planned to be
randomised and three subjects were available in case a subject
became ill or did not eat at least 95% of the weight of the test
meal in the ﬁrst test period. Subjects who met all the inclusion
criteria and had none of the exclusion criteria were considered
for participation (see online Supplementary Table S1). The study
was conducted according to the principles of Good Clinical
Practice, the Declaration of Helsinki (2008) and according to
applicable local laws and regulations concerning studies con-
ducted on human subjects. Ethical approval was obtained from
the Medical Ethics Committee of the ‘Beoordeling Ethiek
Biomedisch Onderzoek’ Foundation (Assen, The Netherlands).
Each participant provided written informed consent for the study.
The trial was registered at clinicaltrialsgov.com as NCT01734590.
Experimental design
This study used a double-blind, randomised, controlled, full
cross-over (within-subject) design. Treatment orders were
balanced according to a Williams-type design, and a randomised
schedule for allocation to treatment orders was generated with
SAS software (version 9.4; SAS Institute Inc.) by a statistician not
involved with subject contact or subsequent data analyses. A
representative of Unilever who was not involved in the analyses
randomly assigned a product (ﬂour mix) to a product code (A/B/
C) and randomly assigned a product code sequence to a subject
number (001–012). The CRO randomly assigned a subject to a
subject number using a computer-generated sequence. All per-
sons involved in the study were blinded as to the nature of the
test products until after the blind data review. One password-
protected memory stick with the personal code-treatment com-
bination was prepared and provided to the study coordinator of
the CRO, to be accessed only if de-blinding of the study was
necessary. The code was not broken during the study.
Subjects attended the initial screening day followed by 3 test
days, at least 1 week apart. Participants were instructed to
minimise changes in their habitual diet and activity during
the study period. The subjects were asked to refrain from
consuming 13C-enriched foods such as maize, pineapple,
Quorn, cane sugar, millet, purslane, tequila and some ﬁshes
(trout, haddock, tuna, whiting), for 3 d preceding the experi-
ments and from exercise and alcohol consumption the day
before each test day. A standardised evening meal consisting of
pasta with vegetables, sauce and meat, a dessert (yogurt, fruit
yogurt or custard) (3912 kJ (935 kcal), 24 percent energy (en%)
protein, 43 en% carbohydrate, 33 en% fat and 13·5 g dietary
ﬁbre) and mineral water was provided at the research facility,
where the subjects stayed overnight. All participants fasted
overnight (from 19.30 hours until consumption of the test
product) but were allowed to drink water ad libitum.
In the evening, a venous catheter was inserted in each sub-
ject’s forearm for blood collection and for infusion of D-[6,6-2H2]
glucose (98% 2H atom percent excess (APE)) (Isotec). In the
morning (t= − 120min), a priming dose of 2H-labelled glucose
(deuterated glucose) (80× 0·07mg/kg body weight (bw)) was
administered as a bolus in 2min in 26·7ml of water followed by a
continuous infusion of 0·07mg/kg bw per min in 0·33ml/min for
8 h. At 2 h after the start of the infusion (t= 0) each morning of
each test day, subjects consumed three freshly made ﬂatbreads
(105 g ﬂour total) with 250ml of mineral water as breakfast, and
completed this within a 15-min period at every visit at the same
time and day of the week. A 5% deviation in consumption of the
standard test product quantity (measured in weight) was
allowed. Subjects were allowed to drink up to 150ml of water
every subsequent hour, to be consumed after venous blood
drawings. The volume of water consumed was recorded on the
1st test day and the same volume of water was consumed on
subsequent test days.
Test product and preparation
The composition of the test products is given in Table 1. For the
ﬂour mix with 2% GG (GG2), a small amount of barley ﬂour (BF)
was added to improve the sensory quality as a prototype of a
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commercially acceptable formulation. On the basis of our previous
results(15,16), the ﬂour mix with 4% GG (GG4) was used as a
positive control and therefore no BF was added. For the control
product (C) a reﬁned wheat ﬂour was used, because this is the
widely used market standard product in India. The coarse ﬂour
was chosen for the experimental product because it also has a
higher dietary ﬁbre content. This was intended to be a test of an
optimised, realistic potential ‘healthier’ commercial product relative
to the current market standard – hence the use of this coarse ﬂour
and also BF in the experimental product (along with CPF and GG).
Our previous research showed PPG responses to the ‘standard’ and
higher ﬁbre atta bases did not differ(16), and it seems unlikely the
small amount of BF would have had much impact. Nevertheless,
results are reﬂecting the total product formulation and cannot be
deﬁnitively assigned to any single component.
Viable wheat seeds (Triticum aestivum L. cv. ‘Sharbati C306’)
were obtained from the Centre for Genetic Resources
(Wageningen, the Netherlands). After germination, the plant
was grown in IsoLife’s labelling facility and continuously
labelled for 15 weeks until maturity in an atmosphere contain-
ing 13CO2 (>97 atom %
13C). After harvesting, the uniformly
13C-labelled seeds (97·1 atom % 13C) were milled (Meneba)
according to the same speciﬁcations (particle size, ash content
and starch damage) as the non-enriched Sharbati whole-wheat
ﬂour from India, obtained from the same cultivar as the 13C-
labelled wheat. After mixing the enriched with non-enriched
ﬂour, all test products obtained a ﬁnal 13C-enrichment of
approximately 2% APE (values for GG2, GG4 and C were 1·97,
1·93 and 2·17%, respectively).
All test ﬂour mixes were formulated in the kitchen of the Con-
sumer Centre of Unilever R&D (Vlaardingen, the Netherlands), and
ﬂatbreads were prepared fresh at the test site in a tortilla roti maker
(Jaipan Jumbo Roti Maker; Jaipan Kitchen Appliances). For each
single test serving, 100g of ﬂour (+5g for kneading) was kneaded
to a soft and uniform consistency with the addition of approxi-
mately 77ml of water and allowed to rest for 30min, and then
divided into three equal balls of each 53g and rolled. More water
was added and absorbed when ﬁbres or legume ﬂour was
incorporated (see Table 1). Flatbreads were subsequently baked
for 15min and kept warm until consumption within 10min after
preparation. The 13C abundance of the 13C-labelled wheat ﬂour
was veriﬁed at 97·05 atom% with isotope ratio MS, and this was
used for the calculation of the kinetic parameters.
Sample collection
Blood samples were collected according to the scheme in the
online Supplementary Table S2. At each time point, blood
was collected in two different blood collection tubes (BD
Vacutainer): NaF-tubes (0·9ml plasma) and K2-EDTA-tubes
(1·35ml plasma), the latter containing dipeptidyl peptidase-IV
inhibitor for GLP-1 and GIP preservation (BD Diagnostics).
After blood collection, tubes were directly mixed by inversion
(eight to ten times) and placed on ice. Within 30min, the tubes
were centrifuged at 1300 g for 10min at 4°C. The resulting
plasma was frozen in 2-ml aliquots at −20°C until analysis.
Isotopic analysis of plasma glucose
To ensure proper calculation of the kinetic parameters (RaE, RaT,
GCR, EGP and RdT), fractional enrichments of orally and intra-
venously administered D-[U-13C] glucose and D-[6,6-2H2] glucose
tracers were determined in the plasma samples at the time points
indicated in the online Supplementary Table S2. Samples were
deproteinised by adding 400μl of ice-cold ethanol to 40 μl
of plasma and placing on ice for 30min. This mixture was
centrifuged for 10min and the supernatant collected for further
analysis. A volume of 200 μl of the supernatant was transferred to
a Teﬂon-capped reaction vial and dried at 60°C under a stream of
N2. To convert glucose to its pentaacetate derivative, 100μl of
pyridine and 200 μl of acetic anhydride were added to the resi-
due, and this mixture was incubated for 30min at 60°C. The
solution was evaporated at 60°C under a stream of N2 and
the residue re-dissolved in 200μl of ethyl acetate. The solutions
were transferred into injection vials for analysis by GC-MS. The
derivatives were separated on AT-1701 30m× 0·25mm internal
diameter (0·25-μm-ﬁlm thickness) capillary column. Mass spectro-
metric analyses were performed using positive chemical ionisa-
tion with ammonia, with ions monitored for mass:charge ratio
(m/z) ranging from m/z 331 to 337 (m0–m6).
Calculation of glucose kinetics
The ﬁrst step in data analysis was the adjustment of the frac-
tional distribution of glucose isotopologues as measured by
GC/MS (m0–m6) for the natural abundance of
13C atoms
(m0–m6), using the method of Lee et al.
(24). Calculations were
performed using the non-steady-state equations of Steele et al.(25)










Control 2·05 2·17 103·0† 69·5 10·1 23·4
GG2 1·84 1·97 83·2¶ 15 2 3 62·5 10·6 24·8
GG4 1·80 1·93 84·2¶ 15 4 61·4 11·6 28·4
GG, guar gum; GG2, 2% GG; GG4, 4% GG.
* To prepare the flatbreads 2·5 g of wheat flour was initially needed to avoid sticking. The amount of 13C-labelled wheat flour is based on this extra 2·5 g of
wheat flour. However, in practice, it was found that 5 g of flour was needed. Although the amount of 13C wheat flour in the flatbread was not corrected for
this change in the amount of extra wheat flour.
† Flour mix Annapurna Atta (100% refined wheat flour; Hindustan Unilever Ltd).
‡ Chickpea flour (99% passing through 420μm; Cardin Healthcare Pvt. Ltd).
§ GG (creamish white powder, 93% passing through 200 mesh; P.D. Bros).
|| Barley flour (dehulled) (99% passing through 420μm; Cardin Healthcare Pvt. Ltd).
¶ Flour mix Annapurna Atta with traditional coarse whole-wheat flour (Hindustan Unilever Ltd).
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as modiﬁed by De Bodo et al.(26). We used an approach
suggested by Radziuk(27), including the assumption that the
clearance rates of all glucose isotopologues, that is, tracers and
tracee, are identical. Furthermore, the volume of glucose
distribution was considered to be 200ml/kg and the pool fraction
0·75(28). The non-steady-state elimination rate of the infused
tracer was initially calculated and used to determine the GCR.
Next, from the GCR and glucose concentrations, the disposal
rates of all glucose isotopologues (RdT), as well as the disposal
rates of glucose that was absorbed from the meals (RdE), can be
calculated. Using the non-steady-state equations, the rates of
appearance (RaT and RaE) can be calculated from these disposal
rates. Finally, the difference between RaT and RaE reﬂects the
EGP rate, that is, EGP.
The primary outcome measure T50%abs was calculated using
the Wagner–Nelson deconvolution method(29). The percentage
of 13C-glucose absorbed at time t (F(t)) was calculated as follows:
F(t)= (AUC(0–t) + glucose(t)/elim.rate)/AUC(0–inf). AUC(0–inf) was
the sum of the actually measured AUC(0–360) and the extrapolated
AUC(360–inf) based on the elimination rate of
13C-glucose in the
terminal phase. AUC(360–inf) was calculated by
13C-glucose
predicted at t= 360min divided by the elimination rate.
Measurement of plasma glucose, insulin, glucagon-like
peptide 1 and glucose-dependent insulinotropic peptide
Plasma glucose concentrations were measured on a Roche/
Hitachi Modular automatic analyser (Roche Diagnostics) using a
glucose hexokinase method. Insulin was measured by a che-
miluminescent microparticle immunoassay (The ARCHITECT®
insulin assay; Abbott Laboratories). GIP was determined by a
RIA(30), based on an antibody that fully reacts with the primary
metabolite GIP3-42. The plasma concentration of GLP-1 was
also analysed by RIA(31), which measured the sum of the intact
GLP-1 and its primary metabolite GLP-1 9-36amide.
Statistical methods
All statistical analyses were performed with SAS version 9.4.
T50%abs was the primary outcome. A power calculation indi-
cated that a minimum of twelve subjects would be needed for
80% power to detect a mean change in T50%abs of 20min at
two-sided signiﬁcance level of 0·05. This estimation was based
on research from Eelderink et al.(21) who used similar techni-
ques to compare wheat bread with pasta, and observed a
38-min difference (SD 11min) in T50%abs. We proposed about
half that effect size as a reasonable basis for power in the
current study (20min).
The responses were summarised as areas under the curve
(AUC(t0–t120min)) over a period of 120min. The AUC was
calculated using the trapezoidal rule(32,33). Values obtained
before consumption of the meal (T= − 60, −30 and −5min)
were averaged and used as the baseline.
For glucose, the positive incremental AUC (+ iAUC(t0–t120min))
was calculated by subtracting 120× baseline glucose value from
the AUC 2h. For RaE, RdT and GCR, +iAUC was calculated
by subtracting 120× baseline values from the AUC(t0–t120min).
For EGP, a decremental AUC (dAUC(t0–t120min)) was calculated
by subtracting the AUC 2 h from 120× baseline EGP. Similar
calculations were also used to derive the data values over
a period of 240min.
The cross-over design aspect of the study was taken into
account when statistically assessing the difference between the
meals for log-transformed AUC, + iAUC or dAUC using a linear
mixed model with subjects as random effect. The model
included the meal, baseline characteristics and visit number as
ﬁxed effects.
The results based on least squares means were expressed as
a percentage change and its 95% CI via back transformation
using the control meal as a reference.
Only the primary objective (T50%abs) underwent pre-planned
statistical hypothesis testing with P< 0·05 as the criterion for
statistical signiﬁcance. A Dunnett adjustment was made to correct
for the proposed multiple comparisons using control as a refer-
ence. For other secondary and exploratory objectives, there was
no pre-planned hypothesis testing and the data are described by
the means and 95% CI. For ease of interpretation, we have,
however, used the convention of describing these results as
‘signiﬁcant’ where the 95% CI does not include 0.
Results
Subjects
From twenty-four male subjects screened for participation, six
were not eligible for the study. In all, eighteen subjects were
eligible for the study and sixteen subjects were selected by lot
as potential participants, one of whom cancelled his participa-
tion for personal reasons before the ﬁrst intervention. In total,
ﬁfteen subjects including three reserve subjects were available,
of whom twelve started and completed the study, with no
dropouts or missing visits (Fig. 1). One subject arrived ill at the
1st intervention day and was replaced by a reserve subject. The
baseline characteristics of participants were as follows: mean
age, 23·0 (SD 2·0) years; height, 186·1 (SD 8·1) cm; bw, 78·7
(SD 8·8) kg; BMI, 22·6 (SD 1·0) kg/m2; fasting plasma glucose, 5·0
(SD 0·4)mmol/l; and glycosylated Hb (HbA1c), 30·7 (SD
3·7)mmol/mol. As blind review identiﬁed only trivial deviations
from protocol, only the results of the per protocol analysis are
shown and discussed here.
Postprandial glucose and insulin response
PPG and PPI response curves are shown in Fig. 2(a) and (b),
respectively, and absolute values and percent differences
between treatments are summarised in Table 2. Compared with
C, GG2 reduced mean + iAUC(t0–t120min) glucose by 14% and
insulin by 16%, whereas GG4 reduced these by 26 and 23%,
respectively.
Glucose kinetics
The T50%abs values did not differ signiﬁcantly between treat-
ments (Table 2).
Glucose kinetics curves are shown for RaE, RaT, EGP and
RdT in Fig. 3(a)–(d), respectively, and for GCR in the online
Supplementary Fig. S1. The absolute values and percent
difference for GG2 and GG4 v. C are summarised in Table 2.
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For all parameters, effects for GG4 were generally larger and
more sustained than for GG2.
As can be seen in Fig. 3(a), from approximately 60 to 150min,
RaE was generally lower for GG2 and GG4 when compared
with C, reﬂected in a reduction in RaE AUC(t0–t240min) (Table 2)
for both GG treatments v. C, which was signiﬁcant only for GG4.
After consumption of GG2 and GG4, EGP was more sup-
pressed compared with C (Fig. 3(c)), reﬂected by a signiﬁcantly
lower AUC(t0–t120min) for GG2 and GG4, and a signiﬁcantly
lower AUC(t0–t240min) for GG4.
RdT was similar for all treatments up to approximately
60min, and from then up to approximately 210min was lower
for GG2 and GG4 relative to C (Fig. 3(d)). This effect was
somewhat more pronounced in GG4 than in GG2, resulting in
signiﬁcant differences from control for both GG2 and GG4 in
AUC(t0–t120min) and in AUC(t0–t240min) only for GG4 (Table 2).
The curves for GCR (online Supplementary Fig. S1) for all
meals were similar to those for RdT. For these curves only the
AUC(t0–t240min) for GG4 was signiﬁcantly different from C
(Table 2).
Data for the cumulative exogenous glucose appearance and
disappearance can be found in Fig. 4 and the online Supple-
mentary Table S3. The cumulative amount of glucose appearing
from exogenous (RaE) and endogenous sources (EGP) for GG4
compared with C was decreased by 2·4 and 2·9 g, respectively,
over 2 h, and by 4·3 and 6·4 g, respectively, over 4 h. The RdT
over the 2-h period was decreased by 5·0 g for GG4, and by and
11·1 g for GG4 at 4 h, compared with C.
Incretin response
GLP-1 and GIP response curves are shown in Fig. 5(a) and (b),
respectively, and the absolute values and percent difference
between treatments are summarised in Table 2. Although GLP-1
did not differ among the treatments, the mean AUC(t0–t240min)
for GIP was somewhat lower after GG4 v. C.
Assessed for eligibility (n 24)
Randomised (n 12)
(3 reserve subjects)
Lost to follow-up (n 0)
15 % CPF + 2 % GG + 3 % BF
(n 12)





















t Excluded (n 6):
Not meeting inclusion crtiteria:
Participation in other clinical trial within 3
months before pre-study examination
Ongoing onychomycosis
Ongoing and long-lasting headache in history
Past medical history









Fig. 1. Flow diagram of participants throughout the study. CPF, chickpea flour; GG, guar gum; BF, barley flour.







































–60 –30 0 30 60 90 120 150 180 210 240 270 300 330 360 390
(a) (b)
Fig. 2. Effects of flatbread consumption with different amounts of guar gum (GG) and legume flour on plasma glucose concentration (a) and plasma insulin
concentration (b). Values are means with their standard errors represented by vertical bars. , Control; , 2% GG; , 4% GG.
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Discussion
Using the dual isotope technique, we found that the lower
glucose response to ﬂatbreads incorporating soluble ﬁbre mixes
was not the result of a reduced absorption rate only, as might be
expected for these ingredients, but reﬂected a greater contribu-
tion from post-absorptive effects (RdT and EGP). The data
suggest that small initial changes in RaE are part of a wider
cascade of metabolic effects including somewhat reduced RdT
and substantial reduction in EGP. These data conﬁrm previous
observations that changes in the rate of intestinal glucose release
from carbohydrate-rich foods and its contribution to the PPG
response cannot be assumed from the response proﬁle itself(21).
For this study, T50%abs was chosen a priori as the primary
objective and RaE as the secondary objective. However, it
appears that T50%abs was less sensitive than RaE as a measure of
change in the rate of release of glucose from the test foods,
probably because the change in T50%abs is based on the
difference of two cumulative curves, whereas RaE is measured
as percentage change.
An explanation of the modest reductions in RaE observed
here may lie in the lower peak values of RaE in C as compared
with previous studies. RaE for all treatments was about 3·1mg/
kg.min (range 2·3–3·4mg/kg.min), whereas Eelderink et al.(23)
reported peak values of about 3·4mg/kg.min and 4·3mg/kg.
min for pasta and bread (50 g available carbohydrates),
respectively(23). In other research, RaE reached values of about
4·3mg/kg.min after wheat bread(34) (50 g available carbohy-
drates) and of about 7·2mg/kg.min after a large meal of either
polished or parboiled rice (5 g dry mass per kg bw)(35). Inter-
estingly, in another study with a ﬂatbread, RaE reached peak
values of 4·0mg/kg.min(36). The low rate of glucose inﬂux from
all ﬂatbreads (including C) in the present study may be attrib-
uted to the denser and drier structure of the product(37)
whereby soluble ﬁbres and legume ﬂours may make only a
modest additional contribution towards further reducing the
inﬂux rate.
Most studies assessing glucose kinetics to foods have com-
pared different foods (e.g. pasta v. wheat bread)(21), rather than
a change in a deﬁned ingredients within the same food format.
An exception is the study by Nazare et al.(38), in which adding
5 g of β-glucan to a polenta meal reduced RaE by 18% during
the ﬁrst 2 h, after which this phenomenon was reversed. Eel-
derink et al.(21) observed that RaE over 2 h was about 30%
lower after pasta as compared with wheat bread.
In addition to getting insight into how the combination of GG
and legume ﬂour in ﬂatbread could inﬂuence the inﬂux of
glucose into the circulation, this study was designed to under-
stand the extent to which absorptive processes and metabolic
handling play a role in total blood glucose and insulin response.
The post-meal glucose and insulin responses in the current
study were in line with our previous results(15,16), which were
powered for PPG as a primary outcome. Other studies(21,39)
have shown similar PPG responses for different treatments, yet
a difference in the RaE, or vice versa. Eelderink et al.(21) found
that the glycaemic response did not differ between pasta and
bread, although the RaE was 30% lower for pasta compared
with bread, and this was compensated by a lower RdT(23). In
contrast, Schenk et al.(39) observed a pronounced difference in
PPG response to two breakfasts with a similar RaE. In that study,
the difference was explained by a difference in RdT. In the
current study, the differences in PPG, especially between GG4
and control, were not only due to a lower RaE but also due to
concurrent, larger reductions in EGP and RdT. Nazare et al.(38)
Table 2. Overview of results for kinetic parameters, glucose, insulin and incretin responses
(Mean values and percentage differences; 95% confidence intervals v. control)
GG2 GG4
Control Mean % Difference* CI Mean % Difference* CI
T50abs† 91·4 95·0 3·6 −7·2, 14·4 95·2 3·8 −7·0, 14·6
RaE AUC0–120 269·3 266·0 −1·3 −13·2, 12·3 242·8 −9·8 −20·7, 2·5
RaE AUC0–240 534·1 515·8 −3·4 −10·6, 4·3 477·8 −10·5 −17·2, −3·4
RaT AUC0–120 512·7 488·6 −4·7 −12·6, 3·9 450·4 −12·1‡ −19·5, −4·1
RaT AUC0–240 970·5 910·7 −6·2‡ −11·3, −0·8 832·5 −14·2‡ −18·9, −9·3
GCR AUC0–120 413·1 402·7 −2·5 −10·4, 6·1 386·3 −6·5 −13·8, 1·5
GCR AUC0–240 882·2 838·8 −4·9 −10·2, 0·6 775·4 −12·1‡ −16·8, −7·1
RdT AUC0–120 486·5 461·3 −5·2 −13·9, 4·4 433·0 −11·0‡ −19·0, −2·2
RdT AUC0–240 967·4 901·5 −6·9‡ −12·3, −0·9 893·5 −14·1‡ −19·0, −8·8
EGP dAUC0−120§ 30·3 41·1 35·6‡ 4·6, 75·9 54·7 80·4‡ 40·3, 131·9
EGP dAUC0–240§ 101·7 104·9 3·2 −35·0, 64·0 166·8 64·1‡ 3·6, 159·9
Glucose AUC0–120 148·9 128·4 −13·8 −27·3, 2·3 110·4 −25·9‡ −37·8, −11·7
Insulin AUC0–120 2322·4 1941·6 −16·4‡ −27·9, −3·1 1787·7 −23·0‡ −33·8, −10·5
Insulin AUC0–240 3541·8 3008·6 −15·1‡ −24·1, −4·9 2749·7 −22·4‡ −30·8, −12·9
GIP AUC0–120 2592·9 2437·8 −6·0 −16·3, 5·6 2323·9 −10·4 −20·2, 0·7
GIP AUC0–240 4862·5 4693·3 −3·5 −13·4, 7·6 4568·2 −6·1 −15·7, 4·7
GLP-1 AUC0–120 1579·2 1513·9 −4·1 −15·6, 8·9 1553·1 −1·7 −13·4, 11·7
GLP-1 AUC0–240 3136·6 3057·6 −2·5 −12·0, 8·0 3062·8 −2·4 −11·9, 8·2
GG2, 2% guar gum; GG4, 4% guar gum; RaE, rate of appearance of exogenous glucose; RaT, rate of appearance of total glucose; GCR, glucose clearance rate; RdT, rate of
disappearance of total glucose; EGP, endogenous glucose production; dAUC, decremental AUC; GIP, glucose-dependent insulinotropic peptide; GLP-1, glucagon-like peptide 1.
* Difference=difference v. control and expressed in % as 100× (GG2−control)/control (similar for GG4), except for T50%abs expressed in min and % change from control.
† Units of RaE, RaT, EGP and RdT are in mg/kg.min of GCR in ml/kg.min. Unit of glucose is mmol/l and insulin is μU/ml. Units of GLP-1 and GIP are pmol/l.
‡ Values indicate outcome where 0 is not contained within the CI.
§ Because EGP was suppressed after the test meals, the area beneath baseline was calculated as dAUC.
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also found that β-glucan added to polenta not only lowered
PPG and RaE but also inhibited EGP to a greater extent.
Similarly, Péronnet et al.(40) found that the exchange of extru-
ded cereals (low slowly digestible starch (SDS) content) for
biscuits (high SDS content) slowed down the availability of
glucose and RaE, and also reduced RdT, whereas the reduction
of EGP was lower(40). This shows that both absorptive pro-
cesses (reﬂected in RaE) and perhaps even more prominently
metabolic handling (reﬂected in RdT and EGP) can all
contribute to the effect of changing carbohydrate type on PPG
response. It underscores that the observation of lower
glycaemic responses (glycaemic index) cannot be interpreted as
indicative of or attributable to signiﬁcantly reduced rates of
release from the food matrix, without additional evidence.
The postprandial increase in RdT was generally reduced by
GG2 and GG4 in the current study, which would tend to
dampen effects on PPG from their lower RaE. Indeed, it has
been shown that a reduced RaE leads to a decreased direct
glucose stimulation of the β-cells and to a low GIP response,
both contributing to a lower insulin response and resulting in a
lower RdT(41). The quantitative cumulative reductions in
glucose inﬂux were largely matched by reductions in glucose
disappearance (Fig. 3(a)), resulting in little net effect on
the overall PPG response. Therefore, the reduction in PPG
responses for GG2 and GG4 reﬂects the additional suppression
of EGP. Given that suppression of EGP is an important action of
insulin, it is of interest to note that the suppression of EGP by
GG4 in particular occurred over a period when insulin levels
were also relatively reduced. This apparent paradox was also
seen in previous studies by Eelderink et al.(23) and Priebe
et al.(34), in which EGP was more suppressed together with
reduced PPI after both pasta compared with wheat bread(23)
and wheat bread compared with glucose(34). In addition,
Nazare et al.(38) found that the addition of β-glucan to a polenta
meal resulted in no differences in plasma insulin levels for
the 1st hour compared with the polenta meal without
β-glucan, together with an enhanced inhibition of EGP. Other
mechanisms for suppression of EGP could be involved, such
as inhibition of glucagon secretion, decrease in release of
NEFA and glycerol from adipose tissue or to a lesser extent
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Fig. 3. Effects of flatbread consumption with different amounts of guar gum (GG) and legume flour on rate of appearance of exogenous glucose (RaE) (a), rate of
appearance of total glucose (RaT) (b), endogenous glucose production (EGP) (c) and rate of disappearance of total glucose (RdT) (d). Values are means with their
standard errors represented by vertical bars. , Control; , 2% GG; , 4% GG.
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gluconeogenic amino acids from skeletal muscles(42); however,
all these mechanisms are also inﬂuenced by insulin. There
might also be a direct effect of plasma glucose concentration
suppressing glucose efﬂux from the liver via the hepatic
glucose-sensing system(43). There might also be a contribution
from production of SCFA by small intestinal fermentation of
ﬁbres(44), stimulating hepatic AMP-activated protein kinase,
which controls liver glucose homoeostasis mainly through the
inhibition of gluconeogenic gene expression and hepatic
glucose production(45). Den Besten et al.(46) indeed showed
in mice that the SCFA uptake ﬂuxes inversely correlated
with genes involved in gluconeogenesis. However, studies
concerning the relationship between SCFA and liver glucose
homoeostasis in humans are lacking(47).
To obtain more information about possible underlying
mechanisms, we also measured the hormones GIP and GLP-1.
These hormones have been shown to affect insulin production
and hepatic glucose production (via glucagon) and could
therefore indirectly inﬂuence glucose kinetics(48,49). In addition,
GLP-1 has been shown to delay gastric emptying, which also
inﬂuences PPG response(50,51). We did not see any effect on
GLP-1 in this study, and a small effect on GIP only for GG4. The
negligible effect on GLP-1 suggests that delivery of glucose to
the GLP-1-producing cells (L-cells) in the distal part of the small









































Fig. 5. Effects of flatbread consumption with different amounts of guar gum (GG) and legume flour on glucagon-like peptide 1 (GLP-1) (a) and glucose-dependent











































Fig. 4. Cumulative appearance of total and exogenous glucose, and glucose from the liver in the peripheral circulation and cumulative disappearance of glucose from
the peripheral circulation. Values are means with their standard errors represented by vertical bars. EPG, endogenous glucose production; RaE, rate of appearance of
exogenous glucose; RaT, rate of appearance of total glucose; RdT, rate of disappearance of total glucose; GG2, 2% guar gum; GG4, 4% guar gum.
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intestine or colon was similar for all treatments. A recent review
has concluded that ﬁbres in general do not increase GLP-1
concentrations compared with control in the acute intake
situation(52) and possibly longer-term consumption of particular
fermentable ﬁbres (e.g. fructo-oligosaccharide) is needed to
increase GLP-1 secretion(53). The lower GIP is likely explained
by the slower digestion rate of the ﬂatbreads with the ﬁbre/ﬂour
mix, as reﬂected by the lower RaE, and as such slower delivery
to GIP-producing K-cells in the duodenum and jejunum(54–56).
In other studies comparing slowly and rapidly absorbed
carbohydrates, there was a strong correlation shown between
GIP and RaE(23,36,40,57).
Lowering insulin and GIP are generally seen as beneﬁcial
physiological effects. In the longer term, regular consumption of
diets with a low PPI response is supposed to improve pan-
creatic β-cell function owing to the lower strain on the β-cells,
especially in individuals with impaired ﬁrst-phase insulin
secretion(58). A lower GIP response may prevent an unhealthy
fat distribution independent of insulin(59).
A limitation of the present study is that the amount of
carbohydrates differed slightly between treatments; however,
these small differences would not realistically explain the
differences in postprandial glucose, insulin and the different
ﬂuxes(60). Furthermore, the amount of carbohydrates was very
similar for GG2 and GG4, yet GG4 was much more effective.
Another limitation is the number of subjects, which is under-
powered for statistical comparison of PPG, but considered
sufﬁcient for estimating ﬂux parameters(60). While the dual
tracer method is suitable for measuring the different glucose
ﬂuxes, it is suggested that a triple tracer methodology can
provide a more accurate assessment of the EGP, RaE and
glucose disposal following ingestion of a carbohydrate-containing
meal(61). A study assessing the accuracy of both techniques
conformed that the triple tracer technique tends to slightly
outperform the dual tracer technique, but the latter beneﬁts from
reduced experimental and computational complexity(62).
The main conclusion of this work is that incorporating GG
and CPF in ﬂatbread only slightly reduced the inﬂux of glucose,
but more substantially affected postprandial disposal, as well as
hepatic glucose production, in healthy subjects. Future research
could test other putative ‘slow-release’ carbohydrates for their
effects on RaE and other ﬂux parameters. At present, these
studies are also quite resource-intense, especially if they require
growing 13C-labelled substrates, and the future development of
alternative methods that do not require this would be advan-
tageous. Another important research question is how these ﬂux
parameters differ in individuals with (pre-) diabetes, and also
whether effects on the different ﬂux parameters contribute to
explaining the associations of different dietary patterns with
disease risk. Last, glucagon should also be measured in future
ﬂux studies, because the ratio between levels of insulin and
glucagon determines EGP and RdT(63).
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